Author:
Shang Xiying,Lin Xinjian,Howell Stephen B
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology,Biochemistry
Reference31 articles.
1. Murai KK, Pasquale EB: 'Eph'ective signaling: forward, reverse and crosstalk. J Cell Sci. 2003, 116: 2823-2832. 10.1242/jcs.00625.
2. Herath NI, Spanevello MD, Sabesan S, Newton T, Cummings M, Duffy S, Lincoln D, Boyle G, Parsons PG, Boyd AW: Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival. BMC Cancer. 2006, 6: 144-10.1186/1471-2407-6-144.
3. Merritt WM, Thaker PH, Landen CN, Deavers MT, Fletcher MS, Lin YG, Han LY, Kamat AA, Schmandt R, Gershenson DM, Kinch MS, Sood AK: Analysis of EphA2 expression and mutant p53 in ovarian carcinoma. Cancer Biol Ther. 2006, 5: 1357-1360. 10.4161/cbt.5.10.3225.
4. Miyazaki T, Kato H, Kimura H, Inose T, Faried A, Sohda M, Nakajima M, Fukai Y, Masuda N, Manda R, Fukuchi M, Tsukada K, Kuwano H: Evaluation of tumor malignancy in esophageal squamous cell carcinoma using different characteristic factors. Anticancer Res. 2005, 25: 4005-4011.
5. Wang XD, Reeves K, Luo FR, Xu LA, Lee F, Clark E, Huang F: Identification of candidate predictive and surrogate molecular markers for dasatinib in prostate cancer: rationale for patient selection and efficacy monitoring. Genome Biol. 2007, 8: R255-10.1186/gb-2007-8-11-r255.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献